Bone Marrow Transplantation - Issue - nature.com science feeds

Second hematopoietic SCT for lymphoma patients who relapse after autotransplantation: another autograft or switch to allograft?

C O Freytes — 2009-11-11

Second hematopoietic SCT for lymphoma patients who relapse after autotransplantation: another autograft or switch to allograft?

Bone Marrow Transplantation 44, 559 (November (1) 2009). doi:10.1038/bmt.2009.214

Authors: C O Freytes & H M Lazarus

HLA matching affects clinical outcome of adult patients undergoing haematopoietic SCT from unrelated donors: a study from the Gruppo Italiano Trapianto di Midollo Osseo and Italian Bone Marrow Donor Registry

R Crocchiolo — 2009-11-11

HLA matching affects clinical outcome of adult patients undergoing haematopoietic SCT from unrelated donors: a study from the Gruppo Italiano Trapianto di Midollo Osseo and Italian Bone Marrow Donor Registry

Bone Marrow Transplantation 44, 571 (November (1) 2009). doi:10.1038/bmt.2009.67

Authors: R Crocchiolo, F Ciceri, K Fleischhauer, R Oneto, B Bruno, S Pollichieni, N Sacchi, M P Sormani, R Fanin, G Bandini, F Bonifazi, A Bosi, A Rambaldi, P E Alessandrino, M Falda & A Bacigalupo

Reduced intensity versus full myeloablative stem cell transplant for advanced CLL

E Peres — 2009-11-11

Reduced intensity versus full myeloablative stem cell transplant for advanced CLL

Bone Marrow Transplantation 44, 579 (November (1) 2009). doi:10.1038/bmt.2009.61

Authors: E Peres, T Braun, O Krijanovski, Y Khaled, J E Levine, G Yanik, K Kato & S Mineishi

Non-intensive treatment with low-dose 5-aza-2′-deoxycytidine (DAC) prior to allogeneic blood SCT of older MDS/AML patients

M Lübbert — 2009-11-11

Non-intensive treatment with low-dose 5-aza-2′-deoxycytidine (DAC) prior to allogeneic blood SCT of older MDS/AML patients

Bone Marrow Transplantation 44, 585 (November (1) 2009). doi:10.1038/bmt.2009.64

Authors: M Lübbert, H Bertz, B Rüter, R Marks, R Claus, R Wäsch & J Finke

Outcome after allogeneic transplantation for adult acute myeloid leukemia patients exhibiting isolated or associated trisomy 8 chromosomal abnormality: a survey on behalf of the ALWP of the EBMT

P Chevallier — 2009-11-11

Outcome after allogeneic transplantation for adult acute myeloid leukemia patients exhibiting isolated or associated trisomy 8 chromosomal abnormality: a survey on behalf of the ALWP of the EBMT

Bone Marrow Transplantation 44, 589 (November (1) 2009). doi:10.1038/bmt.2009.68

Authors: P Chevallier, M Labopin, A Nagler, P Ljungman, L F Verdonck, L Volin, A R Zander, J Finke, G Socie, C Cordonnier, J-L Harousseau, M Mohty & V Rocha

Impact of PCR-based diagnosis of invasive pulmonary aspergillosis on clinical outcome

E Hardak — 2009-11-11

Impact of PCR-based diagnosis of invasive pulmonary aspergillosis on clinical outcome

Bone Marrow Transplantation 44, 595 (November (1) 2009). doi:10.1038/bmt.2009.65

Authors: E Hardak, M Yigla, I Avivi, O Fruchter, H Sprecher & I Oren

Characteristics and risk factors of oral mucositis after allogeneic stem cell transplantation with FLU/MEL conditioning regimen in context with BU/CY2

S Vokurka — 2009-11-11

Characteristics and risk factors of oral mucositis after allogeneic stem cell transplantation with FLU/MEL conditioning regimen in context with BU/CY2

Bone Marrow Transplantation 44, 601 (November (1) 2009). doi:10.1038/bmt.2009.66

Authors: S Vokurka, K Steinerova, M Karas & V Koza

Ethical reasoning about patient eligibility in allogeneic BMT based on psychosocial criteria

L W Foster — 2009-11-11

Ethical reasoning about patient eligibility in allogeneic BMT based on psychosocial criteria

Bone Marrow Transplantation 44, 607 (November (1) 2009). doi:10.1038/bmt.2009.58

Authors: L W Foster, L McLellan, L Rybicki, T Tyler & B J Bolwell

Factors predicting allogeneic PBSCs yield after G-CSF treatment in healthy donors

E Brissot — 2009-11-11

Factors predicting allogeneic PBSCs yield after G-CSF treatment in healthy donors

Bone Marrow Transplantation 44, 613 (November (1) 2009). doi:10.1038/bmt.2009.60

Authors: E Brissot, P Chevallier, T Guillaume, J Delaunay, S Ayari, V Dubruille, S Le Gouill, B Mahe, T Gastinne, N Blin, B Saulquin, G Flandrois, A Devys, V Stocco, A Cesbron, F Dehaut, P Moreau, J-L Harousseau & M Mohty

Successful engraftment of cord blood following a one-day reduced-intensity conditioning regimen in two patients suffering primary graft failure and sepsis

I Shimizu — 2009-11-11

Successful engraftment of cord blood following a one-day reduced-intensity conditioning regimen in two patients suffering primary graft failure and sepsis

Bone Marrow Transplantation 44, 617 (November (1) 2009). doi:10.1038/bmt.2009.69

Authors: I Shimizu, H Kobayashi, K Nasu, F Otsuki, T Ueki, M Sumi, M Ueno, N Ichikawa & S Nakao